Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added site revision notice: Revision: v3.4.2. Removed the earlier funding-lapse notice (Revision: v3.4.1) from the page.
    Difference
    0.4%
    Check dated 2026-02-11T02:37:34.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a global notice about a lapse in government funding and NIH Clinical Center operations, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:56:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Minor UI and metadata updates include showing the glossary toggle, adding QC-related metadata (Last Update Submitted that Met QC Criteria), No FEAR Act Data, and Revision: v3.4.0, while replacing older labels such as Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T21:15:44.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Locations are now presented under a single Locations header listing Alabama, California, and Georgia; the separate Alabama Locations, California Locations, and Georgia Locations sections were removed. The HHS Vulnerability Disclosure footer link has been removed in the update.
    Difference
    0.5%
    Check dated 2025-12-23T00:36:06.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The change is a minor revision label update on the page (from v3.3.1 to v3.3.2) with no impact on the study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T12:45:17.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.3.1 is now displayed, replacing v3.2.0. This is a minor administrative update and does not alter study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:15:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.